» Articles » PMID: 16207330

Identification of Kinectin As a Novel Behçet's Disease Autoantigen

Overview
Publisher Biomed Central
Specialty Rheumatology
Date 2005 Oct 7
PMID 16207330
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

There has been some evidence that Behçet's disease (BD) has a significant autoimmune component but the molecular identity of putative autoantigens has not been well characterized. In the initial analysis of the autoantibody profile in 39 Chinese BD patients, autoantibodies to cellular proteins were uncovered in 23% as determined by immunoblotting. We have now identified one of the major autoantibody specificities using expression cloning. Serum from a BD patient was used as a probe to immunoscreen a lambdaZAP expression cDNA library. Candidate autoantigen cDNAs were characterized by direct nucleotide sequencing and their expressed products were examined for reactivity to the entire panel of BD sera using immunoprecipitation. Reactivity was also examined with normal control sera and disease control sera from patients with lupus and Sjögren's syndrome. Six independent candidate clones were isolated from the cDNA library screen and were identified as overlapping partial human kinectin cDNAs. The finding that kinectin was an autoantigen was verified in 9 out of 39 (23%) BD patient sera by immunoprecipitation of the in vitro translation products. Sera from controls showed no reactivity. The significance of kinectin as a participant in autoimmune pathogenesis in BD and the potential use of autoantibody to kinectin in serodiagnostics are discussed.

Citing Articles

Innate immune responses in Behçet disease and relapsing polychondritis.

Shimizu J, Murayama M, Mizukami Y, Arimitsu N, Takai K, Miyabe Y Front Med (Lausanne). 2023; 10:1055753.

PMID: 37435539 PMC: 10331610. DOI: 10.3389/fmed.2023.1055753.


An Autoantigen Atlas From Human Lung HFL1 Cells Offers Clues to Neurological and Diverse Autoimmune Manifestations of COVID-19.

Wang J, Zhang W, Roehrl V, Roehrl M, Roehrl M Front Immunol. 2022; 13:831849.

PMID: 35401574 PMC: 8987778. DOI: 10.3389/fimmu.2022.831849.


Serum anti-SERPINE1 antibody as a potential biomarker of acute cerebral infarction.

Kubota M, Yoshida Y, Kobayashi E, Matsutani T, Li S, Zhang B Sci Rep. 2021; 11(1):21772.

PMID: 34741085 PMC: 8571331. DOI: 10.1038/s41598-021-01176-8.


A Master Autoantigen-ome Links Alternative Splicing, Female Predilection, and COVID-19 to Autoimmune Diseases.

Wang J, Roehrl M, Roehrl V, Roehrl M bioRxiv. 2021; .

PMID: 34373855 PMC: 8351778. DOI: 10.1101/2021.07.30.454526.


Association of serum levels of antibodies against ALDOA and FH4 with transient ischemic attack and cerebral infarction.

Wang H, Lu H, Zhang X, Goto K, Kobayashi E, Yoshida Y BMC Neurol. 2021; 21(1):274.

PMID: 34243715 PMC: 8268454. DOI: 10.1186/s12883-021-02301-w.


References
1.
Wang D, Buyon J, Zhu W, Chan E . Defining a novel 75-kDa phosphoprotein associated with SS-A/Ro and identification of distinct human autoantibodies. J Clin Invest. 1999; 104(9):1265-75. PMC: 409828. DOI: 10.1172/JCI8003. View

2.
Wang H, Su Y, Han K, Pang X, Peng J, Liang B . Multiple variants and a differential splicing pattern of kinectin in human hepatocellular carcinoma. Biochem Cell Biol. 2004; 82(2):321-7. DOI: 10.1139/o04-003. View

3.
Ochs R, Muro Y, Si Y, Ge H, Chan E, Tan E . Autoantibodies to DFS 70 kd/transcription coactivator p75 in atopic dermatitis and other conditions. J Allergy Clin Immunol. 2000; 105(6 Pt 1):1211-20. DOI: 10.1067/mai.2000.107039. View

4.
Vignal E, Blangy A, Martin M, Gauthier-Rouviere C, Fort P . Kinectin is a key effector of RhoG microtubule-dependent cellular activity. Mol Cell Biol. 2001; 21(23):8022-34. PMC: 99969. DOI: 10.1128/MCB.21.23.8022-8034.2001. View

5.
Mor F, Weinberger A, Cohen I . Identification of alpha-tropomyosin as a target self-antigen in Behçet's syndrome. Eur J Immunol. 2002; 32(2):356-65. DOI: 10.1002/1521-4141(200202)32:2<356::AID-IMMU356>3.0.CO;2-9. View